Carmustine Export Market Intelligence: India's 50 Suppliers Shipping to 54 Countries — TransData Nexus 2026

Q: Who are the top carmustine exporters from India?

The top carmustine exporters from India are: 1. EMCURE PHARMACEUTICALS LIMITED — $17.1M (76.1% market share); 2. MSN LABORATORIES PRIVATE LIMITED — $2.4M (10.6% market share); 3. INTAS PHARMACEUTICALS LIMITED — $778.2K (3.5% market share); 4. THERDOSE PHARMA PRIVATE LIMITED — $455.2K (2.0% market share); 5. SP ACCURE LABS PRIVATE LIMITED — $229.6K (1.0% market share). Together they account for 93.1% of India's total carmustine export value.

Q: What is the total export value of carmustine from India?

The total export value of carmustine from India is $22.5M USD, recorded across 340 shipment transactions from 50 active exporters to 54 destination countries. The average shipment value is $66.2K.

Q: Which countries import carmustine from India?

India exports carmustine to 54 countries worldwide. The top importing countries are: UNITED KINGDOM (58.1% share, $13.1M), CANADA (12.6% share, $2.8M), MALTA (8.7% share, $2.0M), UNITED STATES (7.9% share, $1.8M), LITHUANIA (2.1% share, $462.6K). These five markets account for 89.4% of total export value.

Q: What is the HS code for carmustine exports from India?

The primary HS code for carmustine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of carmustine exports from India?

The average unit price for carmustine exports from India is $116.59 USD per unit, with prices ranging from $0.01 to $9151.92 depending on formulation, packaging, and order volume. The total market is valued at $22.5M across 340 shipments.

Q: Which ports handle carmustine exports from India?

The primary ports for carmustine exports from India are SAHAR AIR (19.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (13.2% of shipments), HYDERABAD AIR (11.2% of shipments), HYDERABAD ACC (INHYD4) (8.2% of shipments), AHEMDABAD AIR ACC (INAMD4) (6.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of carmustine?

India is one of the world's leading exporters of carmustine due to its large base of 50 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports carmustine to 54 countries, demonstrating 28% global market coverage.

Q: What certifications do Indian carmustine exporters need?

Indian carmustine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import carmustine from India?

There are 135 registered buyers importing carmustine from India, spread across 54 countries. The repeat buyer rate is 52.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top carmustine supplier from India?

EMCURE PHARMACEUTICALS LIMITED is the leading carmustine exporter from India with a market share of 76.1% and total export value of $17.1M across 81 shipments. The top 5 suppliers together control 93.1% of total export value.

Suresh Sormare

Carmustine

India Pharmaceutical Trade Intelligence

$22.5M50 Suppliers54 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM58.1%India → CANADA12.6%

ImportsAUSTRALIA → India$6.1K TAIWAN → India$153

#1 Supplier: EMCURE PHARMACEUTICALS

Carmustine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Carmustine to the World

Between 2022 and 2026, India exported $22.5M worth of carmustine across 340 verified shipments to 54 countries — covering 28% of world markets in the Advanced Oncology segment. The largest destination is UNITED KINGDOM (58.1%). EMCURE PHARMACEUTICALS LIMITED leads with a 76.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Carmustine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Carmustine export data snapshot — $22.5M · 50 exporters · 54 countriesTransData Nexus · Indian Customs Data

Top Carmustine Exporters from India

50 active exporters · Ranked by export value

View all 50 →

Top Carmustine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	EMCURE PHARMACEUTICALS LIMITED	$17.1M	81	19	76.1%
2	MSN LABORATORIES PRIVATE LIMITED

Top Countries Importing Carmustine from India

54 destination markets · Ranked by import value

All 54 countries →

Top Countries Importing Carmustine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED KINGDOM	$13.1M	58.1%
2	CANADA	$2.8M	12.6%
3	MALTA	$2.0M	8.7%
4	UNITED STATES	$1.8M	7.9%
5	LITHUANIA	$462.6K	2.1%
6	TAIWAN	$344.6K	1.5%
7	NETHERLANDS	$294.7K	1.3%
8	HONG KONG	$257.2K	1.1%
9	COLOMBIA	$256.2K	1.1%
10	ITALY	$208.8K	0.9%

UNITED KINGDOM is India's largest carmustine export destination, absorbing 58.1% of total exports worth $13.1M. The top 5 importing countries — UNITED KINGDOM, CANADA, MALTA, UNITED STATES, LITHUANIA — together account for 89.4% of India's total carmustine export value. The remaining 49 destination countries collectively receive the other 10.6%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Carmustine to India?

2 origin countries · Total import value: $6.2K

India imports carmustine from 2 countries with a combined import value of $6.2K. The largest supplier is AUSTRALIA ($6.1K, 1 shipments), followed by TAIWAN. All values are from Indian Customs (DGFT) import records.

Countries Supplying Carmustine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	AUSTRALIA	$6.1K	1	97.5%
2	TAIWAN	$153	1	2.5%

AUSTRALIA is the largest supplier of carmustine to India, accounting for 97.5% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Carmustine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, carmustine is approved under multiple Abbreviated New Drug Applications (ANDAs), indicating the presence of generic versions in the market. The FDA's Orange Book lists several approved ANDAs for carmustine, reflecting its established use in oncology. As of March 2026, there are no active import alerts related to carmustine, suggesting compliance with FDA regulations. The regulatory pathway for carmustine involves submission of an ANDA, demonstrating bioequivalence to the reference listed drug, and adherence to Current Good Manufacturing Practices (CGMP). Given that 7.9% of India's carmustine exports are directed to the U.S., it is imperative for Indian exporters to maintain stringent quality standards to ensure market access.

2EU & UK Regulatory Framework

In the European Union, carmustine has been granted marketing authorization as a generic medicine. For instance, Carmustine medac received approval from the European Medicines Agency (EMA) on July 18, 2018. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and monitoring of carmustine products within the UK. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturers, ensuring product quality and safety. With the United Kingdom accounting for 58.1% of India's carmustine exports, adherence to these regulatory standards is crucial for market retention.

3WHO Essential Medicines & Global Standards

Carmustine is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in cancer treatment. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), which set the quality standards for pharmaceutical substances. These inclusions facilitate international trade and acceptance of carmustine, provided that manufacturers comply with the specified standards.

4India Regulatory Classification

In India, carmustine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription drug requiring medical supervision. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, carmustine is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC), ensuring that domestic supply is not adversely affected by international trade.

5Patent & Exclusivity Status

The primary patents for carmustine have expired, leading to the availability of generic versions and increased competition in the market. This generic competition has contributed to the widespread availability and affordability of carmustine globally.

6Recent Industry Developments

In February 2026, the UK's MHRA issued a Class 2 Medicines Recall for a batch of Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion, due to an out-of-specification test result. (gov.uk) This recall highlights the critical importance of stringent quality control measures for manufacturers and exporters.

Additionally, in March 2026, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for a new generic version of carmustine, indicating ongoing developments and approvals within the European market. These regulatory activities underscore the dynamic nature of the pharmaceutical landscape and the necessity for continuous compliance with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Carmustine

Retail & reference prices across 4 markets vs. India FOB export price of $116.59/unit

Global Price Benchmark for Carmustine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
Australia	Approximately $8,500 per implant	AUD	According to the Pharmaceutical Benefits Scheme (PBS), carmustine implants are listed under restricted benefits. (pbs.gov.au)
Iraq	Not specified	IQD	Carmustine 100 mg injection is included in Iraq's Essential Drugs List. (cdn-test-cms.who.int)
Libya	Not specified	LYD	Carmustine 100 mg vials are listed in Libya's Essential Medicines List. (cdn.who.int)
Syria	Not specified

Supply Chain Risk Assessment — Carmustine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Carmustine, an alkylating agent used in chemotherapy, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) often relies on Key Starting Materials (KSMs) sourced from China. This dependency exposes the supply chain to risks associated with geopolitical tensions and trade restrictions. For instance, in October 2025, the U.S. Pharmacopeia reported that nearly 41% of KSMs used in U.S.-approved APIs are sole-sourced from China, highlighting a significant vulnerability in the pharmaceutical supply chain.

Recent disruptions have further exacerbated these risks. In March 2026, the closure of the Strait of Hormuz following military conflicts led to significant delays in the shipment of chemical feedstocks, including those essential for API production. This disruption has caused procurement delays and forced some facilities to reduce output or declare force majeure.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in Carmustine exports from India. The top five exporters account for 93.1% of the total export value, with EMCURE PHARMACEUTICALS LIMITED alone contributing 76.1%. Such concentration poses a significant single-source risk; any operational or regulatory issues affecting these key suppliers could disrupt the entire supply chain.

Access Complete Carmustine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 340 transactions across 54 markets.

Request Demo View Pricing

Frequently Asked Questions — Carmustine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top carmustine exporters from India?

The leading carmustine exporters from India are EMCURE PHARMACEUTICALS LIMITED, MSN LABORATORIES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, and 7 others. EMCURE PHARMACEUTICALS LIMITED leads with 76.1% market share ($17.1M). The top 5 suppliers together control 93.1% of total export value.

What is the total export value of carmustine from India?

The total export value of carmustine from India is $22.5M, recorded across 340 shipments from 50 active exporters to 54 countries. The average shipment value is $66.2K.

Which countries import carmustine from India?

India exports carmustine to 54 countries. The top importing countries are UNITED KINGDOM (58.1%), CANADA (12.6%), MALTA (8.7%), UNITED STATES (7.9%), LITHUANIA (2.1%), which together account for 89.4% of total export value.

What is the HS code for carmustine exports from India?

The primary HS code for carmustine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Carmustine

Carmustine

Top Carmustine Exporters from India

Top Countries Importing Carmustine from India

Who Supplies Carmustine to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Carmustine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Carmustine

Supply Chain Risk Assessment — Carmustine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Carmustine Trade Intelligence

Frequently Asked Questions — Carmustine Exports from India

Who are the top carmustine exporters from India?

What is the total export value of carmustine from India?

Which countries import carmustine from India?

What is the HS code for carmustine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of carmustine exports from India?

Which ports handle carmustine exports from India?

Why is India a leading exporter of carmustine?

What certifications do Indian carmustine exporters need?

How many buyers import carmustine from India?

What is the market share of the top carmustine exporter from India?

Analysis Methodology